Devatis Gains Strong Media Coverage in Mexico Following Successful Launch

Following our participation in Facofest, Mexico’s largest ophthalmology congress, Devatis has received significant media attention in the country. During the event, we introduced Mexico’s first fusidic acid product, marking a key milestone in our commitment to pharmaceutical excellence.

Devatis CEO Philipp Haas engaged with the Mexican media, discussing the growth potential of the country’s pharmaceutical sector and Devatis’ strategic expansion in the region. His insights were featured in multiple leading publications, emphasizing the importance of high-quality pharmaceuticals in emerging markets.

The event and subsequent media engagement have strengthened Devatis’ brand presence in Mexico, reinforcing our commitment to excellence in every dose.